Invention Grant
- Patent Title: KCNQ2-5 channel activator
-
Application No.: US15515243Application Date: 2015-10-23
-
Publication No.: US09809544B2Publication Date: 2017-11-07
- Inventor: Kentaro Yashiro , Daisuke Wakamatsu , Tetsuji Saito
- Applicant: Ono Pharmaceutical Co., Ltd.
- Applicant Address: JP Osaka
- Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2014-217540 20141024
- International Application: PCT/JP2015/080034 WO 20151023
- International Announcement: WO2016/063990 WO 20160428
- Main IPC: C07D213/61
- IPC: C07D213/61
Abstract:
The present invention relates to a compound, 1-[(5-chloro-2-pyridinyl)methyl]-3-{2,6-dichloro-4-[(2S)-1,1,1-trifluoro-2-hydroxy-2-propanyl]phenyl}urea, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20170217888A1 KCNQ2-5 CHANNEL ACTIVATOR Public/Granted day:2017-08-03
Information query
